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Stakeholder perceptions and operational
barriers in the training and distribution of
take-home naloxone within prisons in
England
Arun Sondhi1* , George Ryan2 and Ed Day3
Abstract
Background: The aim of the study was to assess potential barriers and challenges to the implementation of
take-home naloxone (THN) across ten prisons in one region of England.
Methods: Qualitative interviews deploying a grounded theory approach were utilised over a 12- to 18-month
period that included an on-going structured dialogue with strategic and operational prison staff from the ten
prisons and other key stakeholders (n = 17). Prisoner perceptions were addressed through four purposive focus
groups belonging to different establishments (n = 26). Document analysis also included report minutes and access to
management information and local performance reports. The data were thematically interpreted using visual
mapping techniques.
Results: The distribution and implementation of THN in a prison setting was characterised by significant barriers and
challenges. As a result, four main themes were identified: a wide range of negative and confused perceptions of THN
amongst prison staff and prisoners; inherent difficulties with the identification and engagement of eligible prisoners;
the need to focus on individual prison processes to enhance the effective distribution of THN; and the need for senior
prison staff engagement.
Conclusions: The distribution of THN within a custodial setting requires consideration of a number of important factors
which are discussed.
Keywords: Naloxone, Opiate-related overdose, Prison
Background
Naloxone is an opioid antagonist that is used to counteract
an overdose of an opioid drug such as heroin. The drug is
used as part of an emergency overdose response, and there
is evidence that mortality rates can be reduced [1]. The use
of take-home naloxone (THN) is seen as part of a package
of interventions aimed at identifying and responding to an
overdose, including use of rescue breathing and calling
medical emergency services. The perceived advantage
of THN is that it can be administered by non-medical
individuals who have received at least some training.
Naloxone can also be seen as a useful medication for
illicit drug users as it has no clear potential for abuse. The
drug can be administered via intramuscular, intravenous,
subcutaneous, or intranasal routes.
The importance of THN within a prison setting is
based on the consistent strong links between substance
misuse and mortality within relatively short time periods
from the point of release from prison. The evidence base
has consistently highlighted the strong links between
substance misuse and mortality at the point of release. A
recent paper [2] suggested that for men released in
Sweden, the estimated probability of death within 5 years
of release was 10.2 % for substance misusers compared
to 3.2 % of non-substance misusers. Similar findings
were shown for women, with 6.5 % probability of death
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for female substance misusers within 5 years of release
compared to 2.6 % for non-substance misusers.
Other research has shown that male prisoners are 29
times more likely and female prisoners 69 times more
likely to die than the general population, with the first
2 weeks a key period for drug-related mortality [3, 4].
Despite the importance of the first 2 weeks as a key
period for intervention, Chang et al. [2] suggest that the
strong probability of death relating to alcohol or drugs
persists beyond the initial release period for up to
5 years. The authors also suggest that the prevalence
rates are not predicted by higher rates of mental health
problems, although there is a recognition that being di-
agnosed with a substance use disorder may ‘mask’ other
prevalent mental health issues. A similar study [5] found
that following the introduction of opiate substitution
therapy (OST) across all prisons in Scotland there was a
40 % reduction in the level of drug-related deaths
12 weeks post-release.
Opiates are involved in 95 % of cases of drug-related
death reported to coroners, with relative youth (being
aged less than 30 years), white ethnicity, involvement in
acquisitive crime (robbery, theft, fraud, burglary, forgery,
handling stolen goods), and prison sentences of less than
2 weeks identified as key risk factors [6]. The length of
sentence may be a key factor in predicting opioid overdose
as very short sentence lengths are unlikely to provide suf-
ficient time for opiate dependence, or other problematic
drug use, to be adequately treated once in prison (due to
the limited likelihood of accessing OST or any clinical or
psychosocial treatment). Moreover, until recently in the
UK, short-term sentences of less than 1 year did not re-
quire an offender to have a probation supervision order
once released from prison, therefore reducing the prob-
ability of an intervention being offered at the immediate
post-release point.
The importance of an intervention for prisoners at the
point of release, and in particular the potential of THN,
has been identified as a key harm reduction measure [7].
This study presents the findings from a qualitative re-
search project that examined the implementation of THN
in ten prisons in a region of England, as part of a wider re-
settlement or ‘Through-The-Gate’ initiative. This central
government policy, which forms part of the ‘Transforming
Rehabilitation’ programme, aims to provide a series of
tailored interventions for substance misusers on their
arrival into an establishment and throughout their time in
custody, as well as providing continuity-of-care arrange-
ments at the point of release in order to support the goals
of abstinence and sustained recovery. For known opiate-
using offenders, ensuring the availability and provision of
THN formed a key component of the programme. The
use of THN as part of the ‘Through-the-Gate’ initiative
is seen as part of a package of interventions aimed at
identifying and responding to an overdose, including
teaching prisoners in the use of rescue breathing and
calling for medical emergency services.
Effectiveness of training
The literature on THN largely focuses on community
provision, with only a small number of localised studies
focusing on its distribution within custodial settings.
Published research within the last 10 years includes of
a range of small-scale studies and one UK-based
randomised-controlled trial (N-ALIVE), whose status
was unclear at the time of writing. Commentators have
highlighted the paucity of research on THN [7, 8]. Whilst
the literature has focused on service user perspectives in
the community, there are considerably fewer studies exam-
ining service provision amongst prisoners, despite the clear
advantages of targeting this group. The focus has been on
testing whether the knowledge imparted during a THN
training session has been maintained at subsequent points
in time thereafter (usually short term from 3–6 months
later). Overwhelmingly, this suggests that service users
(usually opiate injectors) are better informed and more
knowledgeable about the risks of overdose, following the
THN training sessions [8–14]. Although a key study
examining mortality rates across Massachusetts between
2002 and 2009 found significant reductions in opiate-
related deaths following a THN training and education
programme [15], a systematic review of the effectiveness of
naloxone distribution programmes in the community [10]
was unable to comment on the effectiveness of THN as a
means of reducing fatal and non-fatal overdose due to
methodological weaknesses in the studies included. Overall,
the majority of injectors who were trained were motivated
to engage with training and were willing to be involved in
the management of overdose, either by themselves or with
peers. In a sample of 70 patients in Birmingham and
London, 80 % of the respondents still had their kits at the
6-month follow-up and reported a high level of knowledge
on the risk of overdose [12]. In addition, the majority have
been found to be comfortable using THN following the
training [16] and are willing to administer the drug when
needed [17]. Overall, the THN training has been described
as enhancing the empowerment and confidence of drug
misusers [9] with the potential to extend the training to
their families and carers [11, 18] as the next step in distrib-
uting kits to those who may use and need them.
The training curricula are poorly described in the
research literature, and there is a concern that studies
which show an immediate improvement in knowledge
following a training session may have little relevance to
an overdose situation sometime in the future. However,
previous studies show that training does provide suffi-
cient knowledge for individuals to effectively administer
naloxone [10]. Moreover, the training of THN may be
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reinforcing other life-saving measures such as rescue
breathing and awareness of the recovery position, and so
bundling the THN training as part of a wider response
strategy to overdose may be just as useful.
The aims of this study were fourfold: firstly, to under-
stand how practitioners could best disseminate naloxone
kits to prisoners at the point of release back into the com-
munity; secondly, to identify barriers in taking up training,
including acceptance of kits by prisoners; thirdly, to
discuss stakeholder perceptions on the use of THN and
finally, to map processes within prisons to identify the
most efficient means by which naloxone kits can reach a
prisoner at the point of release. It should be noted that
the distribution of THN was aimed at potential future
drug use once released and back into the community, and
there was no expectation that prisoners could access THN
kits within the prison itself for use in the establishment.
During the time of the study, there had been one possible
opioid-related death although this had not been confirmed
in the coroner’s report.
Methods
The analytical approach for this study utilised grounded
theory [19–22] to understand the stakeholder voices and
perceptions underpinning the THN training and subse-
quent implementation. The goal was to generate theories
to explain why there may be barriers in the delivery of
THN within a custodial environment. Grounded theory
has a number of key features [23] that allow for a concur-
rent data collection and analysis process across a potentially
wide range of sources. Integral to this approach is the con-
cept of ‘theoretical sensitivity’ which is dependent on the
creation of an analytical coding structure that is not based
upon ideas or theoretical frameworks prior to the research.
Theoretical sensitivity is developed through immersion in
the data collected which allows for a deeper and richer
understanding of what participants consider significant or
important. The analysis is undertaken in ‘real time’, which
then influences the direction of the next stage of interviews
and is explicitly aimed at the development of a theory
through ‘theoretical sampling’ [19]. For this study, the
process incorporated a number of formal and structured
real-time discussions alongside more informal conversa-
tions over a period of 12–18 months, with a range of stra-
tegic and operational stakeholders—a mix of healthcare
leads and substance misuse service staff—tasked with the
implementation of THN across the ten prisons (n=17). This
allowed for the analysis for ‘constant comparisons’ across
the various datasets to allow for similarities or discrepancies
in order to develop the theoretical frameworks [19].
A description of the participating prisons is shown in
Table 1.
The range of interviewees included prison representa-
tives from healthcare and substance misuse services,
alongside strategic leads for NHS England and represen-
tatives from Martindale Pharma, who supplied the
naloxone injection kits. Four focus groups (n=26) of
male prisoners were interviewed on their views on
participating in the training within 1 month of the first
session. Interviews were manually recorded using
paper-and-pen methods by one of the research team.
The qualitative interviews were facilitated by a local
Naloxone Action Group, which was formed to monitor and
present progress in implementation, as well as highlighting
and addressing any barriers. The membership of the group
included prison representatives across substance misuse
teams and healthcare services. The group met on a quar-
terly basis (five meetings in total), and in-between a spread-
sheet that included a specific section examining barriers
and potential solutions was sent to all prisons, highlighting
the number of prisoners trained to use THN. The main
issues arising from the spreadsheet were analysed on a
thematic basis. The discussions took place at operational
and strategic review meetings that specifically addressed a
range of implementation issues. These discussions were in
part framed by the grounded theory approach which
included the need to identify operational aspects from a
provider perspective; the routine identification of service
user perspectives, including reasons for refusing to be
involved in the implementation of THN; and wider per-
spectives from prison and community-based staff involved
with the delivery of THN either in prison or on-release.
The study included a range of complementary sources that
could form part of a wider narrative [24], including written
papers prepared for stakeholder meetings, and performance
reporting on the number of prisoners who had been trained
prior to release. These papers often formed discussion
points within the meetings that allowed for a greater
exploration of issues and potential solutions.
Information was collated at each discussion point or
meeting with the aim of deriving themes from the data.
As part of the grounded theory approach, a broad
inductive or data-driven approach was deployed that
did not adhere to any pre-conceived themes. The main
approach relied on visual node-link mapping to identify
themes from the notes taken at meetings and during
the formal interview process, as this method has been
shown to help gain a better understanding of complex
and ambiguous problems by illustrating influence or
causality between factors [25, 26]. This approach utilised
the key stages advocated in the qualitative research lit-
erature [27] through familiarisation with the informa-
tion collected by immersion in the available data (e.g.
through reading interview notes and transcripts) and
recording emerging thoughts and recurrent themes;
identification of a thematic framework; indexing codes
that link to the themes identified; rearranging data
according to the part of the themes identified and
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mapping and interpreting the data by using visual cues
to define any emerging issues.
Results and discussion
This section provides an overview of the key themes
emerging from the action research and the ‘real-time’
discussions with stakeholders, including operational/
strategic staff and from focus groups of prisoners. A
number of key challenges and operational barriers were
identified in this process.
Negative and confused perceptions of THN amongst
prison staff and prisoners
Some prisoners interviewed in the focus groups
expressed a degree of uncertainty about the concept of
THN and what it aimed to achieve. Some interviewees
confused naloxone with naltrexone, an opioid antag-
onist that is used to help people who have stopped
drinking alcohol or using opioid drugs to maintain
abstinence. More significantly, there was confusion
amongst prisoners about the overarching message
underpinning the use of THN within a prison context,
because the primary goal of many prisoners in a treat-
ment setting was to abstain from using any substance.
For instance:
Since I’ve come to this jail, everyone [has been]
banging on about getting myself sorted and off the
drugs and everything you know. It’s taken a while
and I’m in the right place to move forward for once,
no more gear – nothing. I’m done with that life…..
I’m clean now with no intention of using, so why do
I need this? [Male prisoner, Prison 5]
This finding supports the conclusions of community-
based research amongst the treatment population [12]
that suggests that once abstinence is achieved, any ac-
knowledgement that future drug use is a possibility repre-
sents a sign of lack of commitment to recovery. This issue
was not specifically covered in the training although did
form part of a subsequent ‘question and answer’ response
for later sessions. Prisoners also highlighted side effects
and the possible unintended consequences of being in the
possession of a THN kit once released. Some were con-
cerned about the perceived side effects of using THN,
including being ‘…put into an instant rattle’, similar to the
‘dope-sickness’ identified by the wider literature [13, 28].
In addition, prisoners were concerned about the possible
criminal-justice consequences of having been found with
a THN kit in their possession. This included the fear of
police or criminal justice services, such as the Probation
Service or the privatised Community Rehabilitation
Companies, who may surmise that carrying a kit implied
active drug-using behaviour (and therefore breach of the
conditions on any supervision arrangement). This was a
key concern that influenced prisoners’ perceptions on the
need for THN training whilst in prison.
What’ll happen is that I will leave here and as soon I get
my feet on the ground the police will stop me, as always,
and say…..’What’s this? You must be using again - you’re
nicked [arrested]'. [Male prisoner, Prison 2]
Similar perceptions existed amongst some prison-based
staff across most disciplines, including healthcare and sub-
stance misuse services. Non-health-related prison staff re-
ported some degree of negativity about the implementation
Table 1 Description of the prisons
Prison Security level Male/female Modal age group Modal sentence length Percentage opiate users of
those known to substance
misuse treatment services (%)
1 Category D/‘open’ Male 30–39 4–9 years 19
2 Category C trainer Male 21–29 4–9 years 74
3 Category B/‘local’
and category A
offenders
Male 21–29 Un-sentenced/remand 82
4 Category B/‘local’ Male 21–29 Un-sentenced/remand 43
5 Category B/‘local’ Male 21–29 Un-sentenced/remand 63
6 Category C trainer Male 21–29 4–9 years 39
7 Category B/‘local’ Male 21–29 Un-sentenced/remand 64
8 Category D/‘open’ Male 21–29 4–9 years 16
9 Category B/‘local’
and young offenders
(aged under 21 years)
Female 30–39 2–3 years 64
10 Category C trainer Male 30–39 2–3 years 3
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of THN. Firstly, there was a perceived disconnect between
the stated aim of THN as a harm reduction measure to
reduce drug-related deaths and the perception that nalox-
one could act as a potential incentive or encouragement for
using drugs again once prisoners went back into the com-
munity. This perception was linked to a ‘safety valve’
hypothesis [29] identified amongst community-based par-
ticipants suggesting that the lack of potential negative con-
sequences could encourage the misuse of opiates.
Many of my staff understand what we are trying to do
here which is get prisoners off drugs and abstinent by
the time they leave here…if not abstinent entirely then
at least in a positon to consider an abstinent life. For
many staff, and it’s not just uniformed staff [prison
officers], just handing out Naloxone give out the
wrong message that says it’s alright now you can keep
on using. I don’t agree with this view myself but I
know they [staff] think it. [Healthcare Manager,
Naloxone Action Group]
This view was made up of two components: confusion
over the abstinence-harm reduction dichotomy described
above and practical concerns regarding the equipment
(such as the needle) that could be utilised for an illicit
drug use. Therefore, there may be a scope to develop a
strategy to inform both practitioners and clients of the
potential benefits of THN, which includes discussion of
how this harm reduction measure is placed within a
recovery context.
Difficulties with the identification and engagement of
prisoners to receive THN training
Staff highlighted pragmatic concerns regarding the iden-
tification of prisoners with a history of opiate use and
the on-going engagement of prisoners across all estab-
lishments. The ability to identify eligible prisoners to
receive training should be a key component in driving a
programme of training. The point at which prisoners
received THN training was often driven by pragmatic
factors such as finding sufficient prisoners to train,
which often worked against the original aim to deliver
training to prisoners near to or at the point of release.
Some staff tried introducing THN to prisoners on arrival
as part of the induction process. This was seen as relatively
ineffective as induction was not conducive to the introduc-
tion of THN in many prisons, because there was limited
opportunity to explain the rationale or to discuss prisoner
concerns in a confidential manner. In addition, staff sug-
gested that prisoners were overwhelmed with the number
of priorities competing for their attention at the point of
induction, and this led to the fear that key messages
regarding THN would be ‘lost’ if it was introduced too
early. However, the staff interviewed preferred to introduce
THN either during the assessment or as part of the care/
recovery-plan process, where there was a greater oppor-
tunity to directly address concerns and misunderstandings.
The staff had considered creating bespoke node-link maps
aimed at addressing the barriers to engagement and
encouragement of training. This evidence-based visual
approach to presenting and discussing information already
forms part of the tailored, therapeutic package of psycho-
social interventions offered to prisoners as part of the UK
Routes to Recovery initiative [30].
Stakeholders also highlighted difficulties in identifying
opiate users in order to target them for training. Systems
were not often established that allowed an automatic
‘flag’ to be added to prisoners known to have a history
of opiate use. There was neither a routine nor a system-
atic way to track prisoners’ activities from their arrival to
discharge that would include information on training
and other needs. All prisons created simple, bespoke
spreadsheets of information that were held by one staff
member who was involved in the project, and concerns
were raised about the need to place the initiative on a
more sustainable footing. One prison was able to identify
prisoners 8 weeks before release and start of the training
programme and provided supplementary ‘clinics’ just
before release in order to test and update knowledge if
required. Here, prison staff undertook additional focus
groups and one-to-one activity with prisoners to reinforce
the messages derived from the training. The prison staff
reported that prisoners who engaged with substance misuse
services were more likely to be contacted than those who
were disengaged or had completed their treatment and
were discharged from the service. Moreover, attempts at
engaging other cohorts of prisoner (for example, through
prison-wide leaflet drops) failed, as few prisoners responded
positively to wider prison-based initiatives. In one establish-
ment, the prison tested a leaflet drop amongst all prisoners
and found only eight prisoners out of a total of 540 leafleted
expressed an interest in the THN training, and of these,
only four attended the subsequent training session.
The staff also discussed targeting specific sub-groups of
prisoners (for example, at different stages in the prison
sentence) and the difficulties inherent in such an approach.
Not only does this approach rely on the intelligent use of
management information systems (as discussed above) but
also on the staff, who are required to establish de facto
criteria as to who should receive the training. For example,
stakeholder interviews suggested that the maximum
impact of THN training would be in prisoners who are
about to be released. As THN packs could not be trans-
ferred across establishments, prisoners who moved to
other prisons before release were therefore deemed ineli-
gible for training, even though they may have expressed an
interest in receiving THN. Targeting prisoners who were
due to be released was simpler for some training prisons
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with longer sentence prisoners, whilst remand prisons
struggled with the prisoner ‘churn’ (the throughput of pris-
oners within a prison); thus, the process used to identify
prisoners on arrival ‘did not catch-up’ with short-term or
remand prisoners who arrived at an establishment and left
within a short period of time. The process of identification
and engagement of suitable prisoners and delivery of train-
ing to them was best suited to prisoners residing in a
particular prison for some time. Short-term or remand
prisoners, an important cohort of prisoners that may
require the training, often did not receive it because of the
speed at which they moved across the criminal justice
system. Prisoners and staff also highlighted the need to
ensure the availability of THN at other key points on a
prisoner’s journey after being released. A number of pris-
oners who were engaged by staff identified the high risk of
possible overdose within hostels or half-way houses imme-
diately after release and also the need for an enhanced
support and access to naloxone at this point.
The training [is] good and I’m glad I have done it, a
real eye opener a lot of stuff I didn’t know. I know a
lot of the lads think that ‘cos they [are not] using in
jail they don’t think they need it but that’s not the
case on the out [outside prison]. Best to get them…
when they hit the hostels and it’s [drugs] around them
again when they might be tempted [to use]. [Male
prisoner, Prison 2]
Realities of distributing THN within a prison setting
The staff highlighted issues with respect to the process of
delivering training and the distribution of kits to prisoners
at the point of release. At the time of the study, only clini-
cians were able to deliver the THN training as part of
Patient Group Directions (PGDs), often within Immediate
Life Support (ILS) training, thereby limiting the possible
avenues by which THN could be introduced to prisoners.
Peer mentors were identified as a potential group who
could support the delivery of THN in prisons, but this
process was just starting during the fieldwork (in April
2015). Moreover, there were important process issues
underpinning the delivery of the actual kits. All ten
prisons highlighted slightly differing approaches to pla-
cing THN kits within a prisoner’s personal property,
including the use of ‘props’ (property) or ‘vals’ (valu-
ables). Although there were broadly consistent proce-
dures, the way an individual’s personal property was
held varied slightly in different establishments. Conse-
quently, the THN kits were often held at different
points and places in the prison system, leading to diffi-
culties in ensuring that the THN kits were distributed
correctly at the point of release. Unlike other system-
wide community-based settings such as Massachusetts
(15), the distribution of the kits was also perceived to
be under the remit of healthcare as ‘medication’, and
only prescribers or staff with the requisite PGDs could
supply the kits directly to prisoners. Clinical staff also
expressed a sense of ‘fear and apprehension’ in allowing
the distribution of THN kits to non-clinical teams. For
some, clinical oversight was necessary to ensure the
safe distribution of THN to prisoners as part of a wider
package of support.
I am very concerned that Naloxone could be given
out by prison officers or anyone else without
healthcare input. The risks will be too great if
something went wrong and the wrong person got
hold of it. [Healthcare nurse, Naloxone Action Group]
As a consequence, the majority of the training delivered
during the lifetime of the fieldwork was placed within a
basic ILS skills training context, which included the wider
relapse prevention and overdose work. There was also a
lack of clarity over whether a THN kit, including an intra-
muscular needle, should be allowed within a court setting
(for prisoners on remand) and whether it should be placed
within their personal possessions. It remained unclear
what would happen to a THN kit in this scenario, with a
suggestion that possession of a kit would be automatically
confiscated. Other procedural problems included contrac-
tual difficulties with some providers. In some prisons, the
introduction of THN had not been embedded within
existing contracts, and thus, there was a concern over
resourcing the THN distribution. There was the possi-
bility that providing this service would lead to problems
accruing elsewhere within the service, balancing the
economic costs of choosing this activity over another
competing demand.
Engagement of senior prison staff is essential
The qualitative interviews also included a strong message
that the cooperation and proactive support of the prison
governor was essential in ensuring progress in the imple-
mentation of the programme. A wider ‘whole systems’
approach was advocated, whereby implementation was
placed within the remit of the prison’s Drug Strategy to
ensure the most effective distribution and to avoid an
unnecessary burden from being placed on the healthcare
teams. For example, one prison highlighted that over 40
staff members, including community representatives, had
been trained in delivering THN. The aim of this approach
was to create a support mechanism by which other prison
staff could help with training or managing processes to
ensure the effective distribution of kits.
Participants believed that engaging the whole prison
system would result in a degree of ‘culture change’,
whereby all the staff could perceive the benefits of THN.
Participants also highlighted the problem-solving nature
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of most prisons. Problems could be solved quickly if they
were identified by the senior management, and there
was sufficient ‘buy-in’ from operational staff. The need
to ensure that the senior prison management are en-
gaged in the programme was considered to be essential.
Conclusions
The findings from the qualitative interviews identified a
range of barriers to the implementation of THN across
ten prisons in one English region. A number of the themes
identified in this study were consistent with the wider
community-focused literature. Despite these similarities,
stakeholders suggested that distribution of THN kits in
prison is a task fraught with difficulties that requires a
‘whole system’ approach. There is a need to simultan-
eously tackle negative staff perceptions and develop clear
processes to ensure eligible prisoners are trained and
given access to the THN kits. The key finding from this
study is that it is insufficient for prisons to merely offer
training and distribute kits to opiate-using prisoners with-
out conducting a more enhanced planning and prepar-
ation process. To achieve this effectively and to minimise
levels of disengagement, two main elements will need to
be addressed.
Firstly, any prison-based training programme needs to
reduce loss of potential trainees through the complexity
of the prison system. This requires a detailed mapping
of prison processes and procedures, where prison staff
establish local processes to identify eligible prisoners
(e.g. opiate users) and intervene at the most effective
point in the prison journey. Prison leadership is import-
ant in ensuring that such processes run effectively, and
any concerns expressed by prison staff are immediately
addressed. This study has suggested that there are mixed
views with respect to the appropriateness of distributing
THN amongst both healthcare staff and prison officers,
and the process of distributing THN kits is different
across prisons. Relying on healthcare teams to be the
sole route for THN delivery may miss other more effi-
cient ways to ensure the kits’ distribution to prisoners at
the point of release, including the prison resettlement
teams. This is mainly a function of the prescribing
described above, and at the time of writing, there were
plans to allow non-clinical staff to distribute THN kits
directly to prisoners.
The problems highlighted in identifying and tracking
opiate users within the prison resulted in key groups
(e.g. remand or short-sentenced prisoners) often being
excluded from the THN distribution process. This is a
major limitation in the design of an effective training and
distribution programme. An alternative option would be to
enhance the coverage of training to all prisoners regardless
of sentence length or time within the criminal justice
system. Given the role of bystanders in providing ILS and
supporting possible overdose situations, there is an oppor-
tunity to widen access to THN training to all prisoners.
This has a number of key advantages. Firstly, widening
coverage will ensure that no prisoners will be missed from
training including those who may be affected by the stigma
of being identified as a drug user. Secondly, it offers the
opportunity to address the tension between providing
harm reduction services within an increasingly abstinence-
driven policy environment. Finally, there is a wider goal of
training prisoners in life-saving techniques that could be
used in other non-overdose-related situations.
The second key finding from this study is the need to
incorporate a more nuanced consideration of the beliefs
and perceptions of prisoners to ensure the effective dis-
tribution of THN within a prison setting. Training pro-
grammes have to provide the basics of life support and
THN injection administration but also need to address
fundamental fears about use of THN in the community.
Prisoners expressed concern over the perceived side
effects of THN, largely based on word-of-mouth discus-
sions with other prisoners. Furthermore, there was the
challenge of providing a harm reduction initiative in a
largely abstinent and recovery-focused environment.
Gaston et al. [12] have highlighted the role stigma plays
amongst service users in recovery in the community,
and prisoners described a mixed message that emphasised
both the desirability for complete abstinence at the point
of release and an acceptance of potential involvement in
drug use at some point post-release from prison.
Consideration should also be given to the time at which
the THN training and the wider offer is made to prisoners.
Training at the initial point of entry into prison was seen as
largely ineffective, because many prisoners were not at a
point to consider naloxone as an intervention option so
soon after arriving at an establishment. Hence, the staff
suggested that it was better to wait until prisoners were
‘settled’ and more amenable to the harm reduction message.
Furthermore, strategies to manage the process of THN
distribution as prisoners move across the criminal justice
system need to be developed. For prisoners on longer
sentences, there seemed little viability in introducing THN
at an early or mid-point in their sentence for the fear of any
learning from the training being lost. Despite this, there is a
need to ensure that prison staff provided a coherent
message about THN throughout a prisoner’s time in the
criminal justice system, as negative attitudes to naloxone
may harden at other points prior to release. Staff suggested
a focus on the attitudes and perceptions of opiate users
whose sentences were coming to an end and stressed the
need to offer a package of support that specifically
addressed prisoner concerns about the use of THN.
Finally, a consistent message should also be provided by
community-based services, including raising awareness of
THN amongst the probation service and local police forces.
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